Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.
- 1 January 1990
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 21 (1), 47-51
- https://doi.org/10.1161/01.str.21.1.47
Abstract
We studied whether hemostatic abnormalities contribute to the increased risk of stroke in patients with nonvalvular atrial fibrillation. Hemostatic function was studied in four age-matched groups: 20 patients with nonvalvular atrial fibrillation and a previous ischemic stroke, 20 patients with nonvalvular atrial fibrillation without a previous stroke, 20 stroke patients with sinus rhythm, and 40 healthy controls. Both groups with nonvalvular atrial fibrillation had significantly higher concentrations of von Willebrand factor, factor VIII:C, fibrinogen, D-dimer (a fibrinolytic product), beta-thromboglobulin, and platelet factor 4; a significantly higher fibrinogen/antithrombin ratio; and significantly higher spontaneous amidolytic activity than the healthy controls. Prekallikrein levels were significantly lower in both groups with nonvalvular atrial fibrillation. Stroke patients with sinus rhythm had normal hemostatic function, normal concentrations of platelet-related factors, and a slightly increased concentration of fibrinopeptide A compared with the healthy controls. Both groups with nonvalvular atrial fibrillation differed from the stroke patients with sinus rhythm as they did from the healthy controls. No difference in hemostatic function was seen between the nonvalvular atrial fibrillation patients with and without a previous ischemic stroke. Thus, alterations in hemostatic function may contribute to the increased risk of stroke in patients with nonvalvular atrial fibrillation.Keywords
This publication has 27 references indexed in Scilit:
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Von Willebrand factor and cardiovascular riskThrombosis Research, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Evidence for a rapid inhibitor to tissue plasminogen activator in plasmaThrombosis Research, 1983
- Evaluation of some coagulation parameters in cerebral ischemiaActa Neurologica Scandinavica, 1983
- A study of hemostasis in ischemic cerebrovascular disease. V. A multivariate evaluation of risk indicators and predictors. Early results of a longitudinal studyThrombosis Research, 1982
- Rapid radioimmunoassay of human fibrinopeptide A — Removal of cross-reacting fibrinogen with bentoniteThrombosis Research, 1980
- Studies of F VIII procoagulant activity in plasma and concentrates using a semi-automated thrombin generation assayThrombosis Research, 1979
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1963